Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
RLAY
RLAY News & Events
-
Add to Watchlist
Trade RLAY Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
RLAY News
Relay Therapeutics Achieves Breakthrough in Drug Trials
May 22 2026
Fool
Relay Therapeutics Shows Strong Performance Post-IPO
May 22 2026
NASDAQ.COM
Relay Therapeutics Achieves Breakthrough in Clinical Trials
May 22 2026
Yahoo Finance
Relay Therapeutics Prices Public Offering at $12.00 per Share
May 21 2026
seekingalpha
Relay Therapeutics Prices Public Offering at $12 per Share
May 21 2026
NASDAQ.COM
Relay Therapeutics Prices Public Offering at $12 per Share
May 21 2026
Newsfilter
Relay Therapeutics Shares Surge 8% Following Positive Analyst Ratings and Drug Results
May 21 2026
Fool
Relay Therapeutics Shares Surge on Bullish Analyst Upgrades
May 21 2026
NASDAQ.COM
Show More News
RLAY Events
05/20 20:30
Deal Size Increased to $275M
The deal size was increased to $275M from $175M and priced below last closing price of $13.02. Jefferies, TD Cowen, Goldman Sachs, Guggenheim and Raymond James are acting as joint book running managers for the offering.
Show More Events
RLAY Monitor News
Relay Therapeutics stock falls amid sector rotation
Jun 04 2026
Relay Therapeutics stock rises after crossing above SMA
Jun 02 2026
Relay Therapeutics Prices Public Offering at $12 per Share
May 21 2026
Relay Therapeutics Reports Promising Data for Zovegalisib in Clinical Trials
May 19 2026
Relay Therapeutics advances Zovegalisib into Phase 3 trials with Pfizer's Atirmociclib
Apr 28 2026
Relay Therapeutics reaches 52-week high amid sector rotation
Apr 02 2026
RLAY Earnings Analysis
No Data
People Also Watch
